Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
Anat Rec (Hoboken) ; 300(8): 1391-1400, 2017 08.
Article in English | MEDLINE | ID: mdl-28371527

ABSTRACT

In marsupials that possess a retinal vasculature, the arterial and venous segments, down to the smallest calibre capillaries, have been shown to occur in pairs. This pattern is seen in the marsupial central nervous system (CNS) but not in other tissues in this group or in any tissues in eutherian mammals. The present study aimed to determine if the gray short-tailed opossum (Monodelphis domestica), a south American marsupial, possesses double retinal vessels. Secondly, we investigated the relationship between vessels and astrocytes and microglia, which are known to play pivotal roles in the blood retinal barrier and immune surveillance respectively. Eyes from M. domestica between 2 months and 33 months of age were examined by bright field and fluorescein angiography, resin histology, and wholemount immunostaining. Retinal vessels in this marsupial always occur in closely related pairs with the arteriolar limb usually on the vitread aspect. Branches penetrate the retina to form layers of paired capillaries as far as the outer nuclear layer. Dense networks of GFAP+ astrocytes enveloped the vitread aspect of vessels. No particularly strong association with blood vessels and ramified Iba1+ and Ib4+ microglia was noted. M. domestica possessed the unusual paired vasculature and capillary loops arrangement previously described in the marsupial CNS. These observations in a small laboratory-friendly marsupial open up new frontiers to investigate the factors that regulate paired blood vessel development and the functional significance of this arrangement when compared to the anastomotic pattern observed in the retina of eutherian mammals. Anat Rec, 300:1391-1400, 2017. © 2017 Wiley Periodicals, Inc.


Subject(s)
Astrocytes/cytology , Microglia/cytology , Monodelphis/anatomy & histology , Retinal Vessels/anatomy & histology , Animals , Fluorescein Angiography
2.
Can J Physiol Pharmacol ; 85(7): 727-38, 2007 Jul.
Article in English | MEDLINE | ID: mdl-17823636

ABSTRACT

Bleomycin-induced lung fibrosis in mice reproduces some key features of pulmonary fibrosis in humans including alveolar inflammation, myofibroblast proliferation, and collagen deposition. Glucocorticoids have been used as first-line therapy for the treatment of lung fibrosis, although their clinical efficacy is equivocal. We examined the effect of the glucocorticoid, methylprednisolone (MP), and the estrogen metabolite, 2-methoxyestradiol (2MEO) on bleomycin-induced bronchoalveolar inflammation, fibrosis, and changes in lung function. The characterization of the time-course of the bleomycin-induced fibrosis indicated that lung dry mass and hydroxyproline content showed less variance than histopathological assessment of fibrosis. The bleomycin-induced increases in bronchoalveolar lavage (BAL) fluid cell number and protein levels were not significantly influenced by treatment with either MP (1 mg.(kg body mass)(-1).day(-1), i.p.) or 2MEO (50 mg.(kg body mass)(-1).day(-1), i.p.). Lung fibrosis, measured histopathologically or by hydroxyproline content, was not significantly influenced by either MP or 2MEO treatment, whereas the latter agent did reduce the increment in lung dry mass. The enlargement of alveolar airspaces and the decline in lung compliance were exacerbated by MP treatment. These data suggest that bleomycin-induced pulmonary fibrosis is resistant to inhibition by concurrent treatment with either glucocorticoids or 2MEO.


Subject(s)
Drug Resistance , Estradiol/analogs & derivatives , Glucocorticoids/therapeutic use , Pulmonary Fibrosis/drug therapy , 2-Methoxyestradiol , Airway Resistance/drug effects , Animals , Bleomycin/toxicity , Body Weight/drug effects , Bronchoalveolar Lavage Fluid/chemistry , Bronchoalveolar Lavage Fluid/cytology , Cell Adhesion Molecules/genetics , Cytokines/genetics , Estradiol/pharmacology , Estradiol/therapeutic use , Gene Expression/drug effects , Glucocorticoids/pharmacology , Hydroxyproline/analysis , Lung/drug effects , Lung/metabolism , Lung/physiopathology , Lung Compliance/drug effects , Matrix Metalloproteinases/genetics , Methylprednisolone/pharmacology , Methylprednisolone/therapeutic use , Mice , Mice, Inbred C57BL , Organ Size/drug effects , Pulmonary Alveoli/drug effects , Pulmonary Alveoli/metabolism , Pulmonary Alveoli/pathology , Pulmonary Emphysema/chemically induced , Pulmonary Emphysema/drug therapy , Pulmonary Emphysema/metabolism , Pulmonary Fibrosis/chemically induced , Pulmonary Fibrosis/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Tissue Inhibitor of Metalloproteinases/genetics , Tubulin Modulators/pharmacology , Tubulin Modulators/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL